Targeting androgen signaling in ILC2s protects from IL-33–driven lung inflammation, independently of KLRG1
Eve Blanquart, Audrey Mandonnet, Marion Mars, Claire Cénac, Nina Anesi, Pascale Mercier, Christophe Audouard, Stéphane Roga, Gilberto S. Almeida, Charlotte L. Bevan, Jean‐Philippe Girard, Lucette Pelletier, Sophie Laffont, Jean‐Charles Guéry
Topics & Concepts
Innate lymphoid cellAndrogen receptorAndrogenInflammationBiologyEndocrinologyDownregulation and upregulationInternal medicineImmunologyImmune systemInnate immune systemMedicineHormoneBiochemistryGeneProstate cancerCancerIL-33, ST2, and ILC PathwaysEosinophilic EsophagitisAsthma and respiratory diseases